Brief: Sk Biopharmaceuticals To Acquire Shares Worth 62 Billion Won In Proteovant Sciences Inc
SK Biopharmaceuticals Co Ltd 326030.KS :
* SK BIOPHARMACEUTICALS: TO ACQUIRE SHARES WORTH 62 BILLION
WON IN
PROTEOVANT SCIENCES INC
Source text for Eikon: ID:
Further company coverage: 326030.KS
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract